Rhythm Pharmaceuticals
RYTM
RYTM
89 hedge funds and large institutions have $973M invested in Rhythm Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 43 increasing their positions, 16 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.91% less ownership
Funds ownership: 99.38% → 96.47% (-2.9%)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
89
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$50.7M | |
| 2 | +$45.9M | |
| 3 | +$42.4M | |
| 4 |
DM
Deerfield Management
New York
|
+$39M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$20.6M |
Top Sellers
| 1 | -$38.5M | |
| 2 | -$15.6M | |
| 3 | -$11.7M | |
| 4 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
-$5.06M |
| 5 |
Millennium Management
New York
|
-$5.01M |